Based on some of the common molecular mechanisms of neurodegeneration, we investigated whether CA-induced CEBPβ inhibition is related to modulations of the glial cascade and exerts neuroprotective effects in an AD cell model in vitro. Here, CEBPB is linked to Alzheimer disease.